Quintero-Sierra Y, Hernández-Padrón C

Idioma: Español
Referencias bibliográficas: 14
Paginas: 265-271
Archivo PDF: 65.29 Kb.

RESUMEN

El linfoma no hodgkiniano parecido al Burkitt es considerado una neoplasia de células B altamente agresiva, con un alto índice de proliferación. Las presentaciones en forma de masas tumorales abdominales no son muy frecuentes y están poco documentadas en la literatura. Se reporta un caso poco usual de un paciente adulto joven con linfoma no hodgkiniano parecido al Burkitt, con infiltración del colon derecho, tratado con poliquimioterapia asociada a la administración de anticuerpo monoclonal anti- CD20, con lo que se alcanzó la remisión completa de la enfermedad. Posteriormente esta respuesta se consolidó con esquemas intensivos de quimioterapia y trasplante de progenitores hematopoyético autólogo. Actualmente se mantiene asintomático y sin tratamiento.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Conroy SM, Maskarinec G, Morimoto Y, Franke AA, Cooney RV, Wilkens LR, et al. No-Hodgkin Lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: The multiethnic Cohort. Cancer Epidemiol Biomarkers. 2013;22(3):337-47.

2. Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012;380(9844):848-57.

3. American Cancer Society: Cancer Facts and Figures 2015. Atlanta, Ga: American Cancer Society, 2015;60(3):664-71.

4. Tan D, Horning SJ, Hoppe RT, Levy R, Rosenberg SA, Sigal BM, et al. Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood. 2013;122(6):981-7.

5. Swedlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA. Classification of Tumours of Haematopoietic and Lymphoid Tissues. Eds. World Health Organization IARC: Lyon; 2008.

6. Hussong JW, Arber DA, Bradley KT, Brown MS, Chung-Che Ch, David ME, et al. Protocol for the Examination of Specimens From Patients With Non-Hodgkin Lymphoma/Lymphoid Neoplasms. Arch Pathol Lab Med. 2010;134(6):e40-e47.

7. Tanaka H, Hashimoto S, Abe D, Sakai S, Takagi T. Double-hit lymphoma at second relapse of Burkitt-like lymphoma: a case report. J Clin Exp Hematop. 2011;51(1):43- 7.

8. Parker SM, Olteanu H, Vantuinen P, Lawton CA, Schultz CJ, Christians KK, et al. Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy. Int J Hematol. 2009;90(5):616-22.

9. Mocumbi AO, Paul L, Maciel L, Silvia P, Ferreira MB. Secondary intracardiac Burkittlike lymphoma in the absence of HIV infection. Cardiovasc J Afr. 2011;22(2):96-7.

10. Thomas DA, O'Brien S, Faderl S, Manning JT, Romaguera J, Fayad L, et al. Burkitt Lymphoma and Atipical Burkitt or Burkitt-like Lymphoma: Should These be Treated as Differente Diseases? Curr Hematol Malig Rep. 2011;6(1):58-66.

11. Kujawski L, Longo WL, Williams EC. High-dose CHOP and midcycle methotrexate for adult Burkitt and Burkitt-like lymphomas. Blood. 2002;100:779a, abstract 3083.

12. Lacasce A, Howard O, Lib S. Modified Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leuk Lymphoma. 2004;45(4):761-7.

13. Cabanillas M, Thomas D, Cortes J. Outcome with hyper-CVAD and rituximab in Burkitt (BL) and Burkitt-like (BLL) leukemia/lymphoma. Proc Am Soc Clin Oncol. 2002;106(7):1569-80.

14. Sweetenham J, Pearce R, Taghipour G, Blaise D, Gisselbrecht C, Goldstone A. Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma: outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation. J Clin Oncol. 1996;14(9):2465-72.